BERKE; Jan Martin

Patent Applications and Registrations

Patent applications and USPTO patent grants for BERKE; Jan Martin.The latest application filed is for "combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai".

Company Profile

3.5.10

BERKE; Jan Martin - Beerse BE
BERKE; Jan Martin - Dusseldorf DE
Berke; Jan Martin - Willebroek BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi App 20220305107 - HORTON; Helen ; et al.	2022-09-29
Combination Of Hepatitis B Virus (hbv) Vaccines And Dihydropyrimidine Derivatives As Capsid Assembly Modulators App 20220249647 - HORTON; Helen ; et al.	2022-08-11
Fused Heterocycle Derivatives App 20220242879 - KUDUK; Scott D. ; et al.	2022-08-04
Combination Of Hepatitis B Virus (hbv) Vaccines And Dihydropyrimidine Derivatives As Capsid Assembly Modulators App 20220233526 - HORTON; Helen ; et al.	2022-07-28
Combinations and methods comprising a capsid assembly inhibitor Grant 11,129,834 - Hartman , et al. September 28, 2	2021-09-28
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases Grant 11,096,931 - Last , et al. August 24, 2	2021-08-24
Amide Derivatives Useful In The Treatment Of Hbv Infection Or Hbv-induced Diseases App 20200352925 - KESTELEYN; Bart Rudolf Romanie ; et al.	2020-11-12
Amide Derivatives Useful In The Treatment Of Hbv Infection Or Hbv-induced Diseases App 20200268730 - LAST; Stefaan Julien ; et al.	2020-08-27
Combinations And Methods Comprising A Capsid Assembly Inhibitor App 20190365767 - Hartman; George ; et al.	2019-12-05
Combinations and methods comprising a capsid assembly inhibitor Grant 10,441,589 - Hartman , et al. Oc	2019-10-15
Combinations And Methods Comprising A Capsid Assembly Inhibitor App 20170340642 - HARTMAN; George ; et al.	2017-11-30
Method For Determining Drug Resistance Mutations In Any Of The Non-structural Protein Regions Ns3 To Ns5b Of Hepatitis C Virus (hcv) For Genotypes 1 To 6 App 20160177407 - Koletzki; Diana ; et al.	2016-06-23
Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6 Grant 8,945,833 - Stuyver , et al. February 3, 2	2015-02-03
Method For Determining Drug Resistance Mutations In Any Of The Non-structural Protein Regions Ns3 To Ns5b Of Hepatitis C Virus (hcv) For Genotypes 1 To 6 App 20110189684 - Stuyver; Lieven Jozef ; et al.	2011-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.